{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:44:32Z","timestamp":1792115072230,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaci.2026.04.017","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:56:00Z","timestamp":1777931760000},"page":"811-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions"],"prefix":"10.1016","volume":"158","author":[{"given":"Chuang-Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ti","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaline","family":"Chung-Yee Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Man","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Iu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang Yu","family":"Huei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichittra","family":"Tassaneeyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew-Eng","family":"Choon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nontaya","family":"Nakkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlaphat","family":"Sukasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Jian","family":"Jan Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yu","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jr-Hau","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Shou","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Shien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Han","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hui","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-En","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu-Wei Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jr","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-0959","authenticated-orcid":false,"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.04.017_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00003495-199550010-00009","article-title":"Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis","volume":"50","author":"Rains","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2026.04.017_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-101-3-377","article-title":"Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development","volume":"101","author":"Peppercorn","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib6","article-title":"Sulfonamide allergies","volume":"7","author":"Giles","year":"2019","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.jaci.2026.04.017_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.017_bib8","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B\u22175801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.04.017_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I\u2013restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.017_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.alit.2024.03.003","article-title":"Clinical characteristics and genetic HLA marker for patients with oxaliplatin-induced adverse drug reactions","volume":"73","author":"Hsu","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.04.017_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell\u2013mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaip.2024.10.027","article-title":"Class I HLA alleles are associated with an increased risk of osimertinib-induced hypersensitivity","volume":"13","author":"Chen","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.017_bib14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/all.13821","article-title":"HLA-B\u221757:01 confers genetic susceptibility to carbamazepine-induced SJS\/TEN in Europeans","volume":"74","author":"Mockenhaupt","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.017_bib15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","article-title":"Impact of the HLA-B(\u2217)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions","volume":"136","author":"Ng","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib16","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1136\/annrheumdis-2014-205577","article-title":"Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin","volume":"74","author":"Chung","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2026.04.017_bib17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12929-022-00845-8","article-title":"Functional and structural characteristics of HLA-B\u221713:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity","volume":"29","author":"Jiang","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jaci.2026.04.017_bib19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jid.2018.02.004","article-title":"The function of HLA-B\u221713:01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions","volume":"138","author":"Chen","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamadermatol.2024.0210","article-title":"Human leukocyte antigens and sulfamethoxazole\/cotrimoxazole-induced severe cutaneous adverse reactions: a systematic review and meta-analysis","volume":"160","author":"Wu","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.04.017_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2026.04.017_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cpt.1190","article-title":"HLA alleles and CYP2C9\u22173 as predictors of phenytoin hypersensitivity in East Asians","volume":"105","author":"Su","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2026.04.017_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1155\/2007\/976804","article-title":"N-Acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease","volume":"21","author":"Chen","year":"2007","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jaci.2026.04.017_bib27","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1038\/s41598-020-60467-8","article-title":"The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis","volume":"10","author":"Yee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.04.017_bib28","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jid.2019.12.025","article-title":"Association of HLA-A\u221711:01 with sulfonamide-related severe cutaneous adverse reactions in Japanese patients","volume":"140","author":"Nakamura","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2217\/pgs.14.69","article-title":"HLA-B\u221713:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population","volume":"15","author":"Yang","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2026.04.017_bib30","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jaip.2024.02.041","article-title":"Association of HLA-A \u221711:01, HLA-B \u221739:01, and HLA-B \u221756:03 with salazosulfapyridine-induced cutaneous adverse drug reactions","volume":"12","author":"Fukunaga","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.017_bib31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1074-7613(01)00252-7","article-title":"CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation","volume":"15","author":"Daniels","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.017_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaci.2013.04.036","article-title":"A new nucleic acid\u2013based agent inhibits cytotoxic T lymphocyte\u2013mediated immune disorders","volume":"132","author":"Wang","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib33","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaip.2020.09.048","article-title":"Detecting lesional granulysin levels for rapid diagnosis of cytotoxic T lymphocyte\u2013mediated bullous skin disorders","volume":"9","author":"Chen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.017_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/all.13235","article-title":"Delayed-type hypersensitivity reactions induced by proton pump inhibitors: a clinical and in vitro T-cell reactivity study","volume":"73","author":"Lin","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.017_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54180-7","article-title":"Immune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockade","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.017_bib36","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/ijd.13350","article-title":"Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression","volume":"55","author":"Weinborn","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/bjd\/ljae375","article-title":"CCR8\/CCL1 and CXCR3\/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity","volume":"192","author":"Chiu","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/ard.2010.139774","article-title":"Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"70","author":"Soliman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2026.04.017_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4997\/jrcpe.2021.306","article-title":"Safety of long-term use of four common conventional disease modifying anti-rheumatic drugs in rheumatoid arthritis","volume":"51","author":"Kedia","year":"2021","journal-title":"J R Coll Physicians Edinb"},{"key":"10.1016\/j.jaci.2026.04.017_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.iac.2022.01.002","article-title":"Advances in the pathomechanisms of delayed drug hypersensitivity","volume":"42","author":"Wang","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2026.04.017_bib41","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib42","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2026.04.017_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41397-020-00187-4","article-title":"HLA-B\u221739:01:01 is a novel risk factor for antithyroid drug\u2013induced agranulocytosis in Japanese population","volume":"21","author":"Nakakura","year":"2021","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2026.04.017_bib45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/cpt.805","article-title":"Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus","volume":"103","author":"Wadelius","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2026.04.017_bib46","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B\u221713:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1183491","article-title":"Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs","volume":"14","author":"Wung","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2026.04.017_bib48","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/s41467-019-11396-2","article-title":"Identification of drug-specific public TCR driving severe cutaneous adverse reactions","volume":"10","author":"Pan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.017_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008571-199704000-00006","article-title":"NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus","volume":"7","author":"Sabbagh","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jaci.2026.04.017_bib50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0889-8553(21)00053-4","article-title":"Sulfasalazine and 5-ASA compounds","volume":"21","author":"Allgayer","year":"1992","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2026.04.017_bib51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2012.10.003","article-title":"Allergy to sulfonamides","volume":"131","author":"Schnyder","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2009.10.031","article-title":"Stimulation of human T cells with sulfonamides and sulfonamide metabolites","volume":"125","author":"Castrejon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfab144","article-title":"Checkpoint inhibition reduces the threshold for drug-specific T-cell priming and increases the incidence of sulfasalazine hypersensitivity","volume":"186","author":"Hammond","year":"2022","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2026.04.017_bib54","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jid.2020.11.027","article-title":"Granulysin-based lymphocyte activation test for evaluating drug causality in antiepileptics-induced severe cutaneous adverse reactions","volume":"141","author":"Chu","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2026.04.017_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaci.2022.12.005","article-title":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","volume":"151","author":"Gibson","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib56","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"Strom","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.017_bib57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000312632","article-title":"Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole","volume":"153","author":"Zawodniak","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.04.017_bib58","article-title":"An updated review of genetic associations with severe adverse drug reactions: translation and implementation of pharmacogenomic testing in clinical practice","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2026.04.017_bib59","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/ncomms8146","article-title":"Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1","volume":"6","author":"Cortes","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.017_bib60","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/mmr.2017.6248","article-title":"Role of HLA-B27 in the pathogenesis of ankylosing spondylitis","volume":"15","author":"Chen","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jaci.2026.04.017_bib61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13075-018-1724-7","article-title":"Influence of HLA-B27 on the ankylosing spondylitis phenotype: results from the REGISPONSER database","volume":"20","author":"Arevalo","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2026.04.017_bib62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/annrheumdis-2018-213779","article-title":"HLA class I and II alleles in susceptibility to ankylosing spondylitis","volume":"78","author":"Reveille","year":"2019","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600299X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492600299X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:51:27Z","timestamp":1792111887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492600299X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S009167492600299X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.017","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}